Literature DB >> 1791202

Molecular specificity of two commercial enzyme linked immunosorbent assays for human immunodeficiency virus antigens.

K E Brown1, D C Shanson, P Mascagni, A R Coates.   

Abstract

Only "fair" agreement has been shown between the Abbott and DuPont enzyme linked immunosorbent assays when used for the detection of human immunodeficiency virus (HIV) antigen in serum samples from asymptomatic HIV antibody positive homosexual men. To investigate the discrepancies between the two ELISA results, further experiments were performed. The rabbit detector antibody solutions of both tests were western blotted and showed that the DuPont test was specific for p24; the Abbott detector antibody had bands for p18, p41-43, gp120 as well as p24. By using dilutions of a known amount of HIV antigen, the Abbott test could detect 20 pg/ml p24; the DuPont test could detect 30 pg/ml p24. The DuPont test was also more sensitive than the Abbott test at detecting a synthetic 104mer peptide of p24. Within the 104mer sequence two regions (294-318, 334-348 amino acids) inhibited the binding of the DuPont detector antibody, but no blocking was observed with the Abbott antibody. Although the Abbott test was slightly more sensitive at detecting HIV protein than the DuPont test, the major difference between the tests was in the molecular specificity, in that the Abbott test detected proteins other than p24. This may not be important for detecting antigen in cell culture, but it may affect the detection of antigenaemia in patients' sera.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1791202      PMCID: PMC494972          DOI: 10.1136/jcp.44.12.1022

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  9 in total

1.  Persistent HIV antigenaemia and decline of HIV core antibodies associated with transition to AIDS.

Authors:  J M Lange; D A Paul; H G Huisman; F de Wolf; H van den Berg; R A Coutinho; S A Danner; J van der Noordaa; J Goudsmit
Journal:  Br Med J (Clin Res Ed)       Date:  1986-12-06

2.  A preliminary evaluation of five HIV antigen detection assays.

Authors:  D S Healey; W J Maskill; E V Neate; F Beaton; I D Gust
Journal:  J Virol Methods       Date:  1988-06       Impact factor: 2.014

3.  Persistence of human immunodeficiency virus antigenemia in patients with the acquired immunodeficiency syndrome treated with a reverse transcriptase inhibitor, suramin. Ten-patient case-control study.

Authors:  J K Eeftinck Schattenkerk; S A Danner; J M Lange; D A Paul; C J van Boxtel; F Miedema; P T Schellekens; J Goudsmit
Journal:  Arch Intern Med       Date:  1988-01

4.  Evaluation of two commercial tests for human immunodeficiency virus antigens in culture supernatant fluid.

Authors:  J B Jackson; K Sannerud; F S Rhame; H H Balfour
Journal:  Am J Clin Pathol       Date:  1988-06       Impact factor: 2.493

5.  Circulation of HIV antigen in blood according to stage of infection, risk group, age and geographic origin.

Authors:  J Goudsmit; D A Paul
Journal:  Epidemiol Infect       Date:  1987-12       Impact factor: 2.451

6.  Effect of zidovudine on serum human immunodeficiency virus antigen levels in symptom-free subjects.

Authors:  F de Wolf; J M Lange; J Goudsmit; P Cload; J de Gans; P T Schellekens; R A Coutinho; A P Fiddian; J van der Noordaa
Journal:  Lancet       Date:  1988-02-20       Impact factor: 79.321

7.  A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections.

Authors:  J T Grayston; C C Kuo; S P Wang; J Altman
Journal:  N Engl J Med       Date:  1986-07-17       Impact factor: 91.245

8.  Blind comparison of Abbott and Dupont HIV antigen ELISA tests for detecting antigenaemia in asymptomatic human immunodeficiency virus antibody positive homosexual men.

Authors:  D C Shanson; K E Brown; S Goonesekera; B Gazzard; A R Coates
Journal:  J Clin Pathol       Date:  1990-05       Impact factor: 3.411

9.  Human immunodeficiency virus (HIV) antigenemia (p24) in the acquired immunodeficiency syndrome (AIDS) and the effect of treatment with zidovudine (AZT).

Authors:  G G Jackson; D A Paul; L A Falk; M Rubenis; J C Despotes; D Mack; M Knigge; E E Emeson
Journal:  Ann Intern Med       Date:  1988-02       Impact factor: 25.391

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.